Pricing Log in Create free account
Saturday 17 October 2026 Export A’s income statement to Excel — free account

Agilent Technologies, Inc.

A Healthcare Diagnostics & Research

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

172.96 2.59 −1.48%
Market cap
$49.5B
P/E
34.0×
Fwd P/E
26.3×
Dividend yield
0.59%
F-score
5/9
Altman Z
5.46
Beneish M
−2.46
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Agilent Technologies, Inc. (A) Debt to equity

Alert me on Debt to equity

Agilent Technologies, Inc.'s debt to equity at the end of the quarter to 31 July 2026 was 0.5×, up 0.0× from fiscal 2025 (0.5×). Over the past ten years it has ranged from 0.4× (fiscal 2017) to 0.6× (fiscal 2024); the current reading is higher than 55% of that period. That is above the Diagnostics & Research industry median of 0.1× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2025 0.5× (20.21%)
FY2024 0.6× 21.20%
FY2023 0.5× (9.18%)
FY2022 0.5× 1.74%
FY2021 0.5× 8.04%
FY2020 0.5× 24.26%
FY2019 0.4× (4.17%)
FY2018 0.4× 5.66%
FY2017 0.4× (16.93%)
FY2016 0.4× 12.98%

Quarterly newest first

Period Debt to equity Change
Jul 2026 0.5× 15.55%
Apr 2026 0.4× (2.97%)
Jan 2026 0.4× (2.43%)
Oct 2025 0.5× (13.96%)
43 more quarters

Against its own ten years

Low 0.4× High 0.6×
Ten-year median 0.5×
Current reading's percentile 55

Debt to equity against peers

Company Debt to equity
NTRA Natera, Inc. compare 0.0×
IDXX IDEXX Laboratories, Inc. compare 0.3×
WAT Waters Corporation compare 0.3×
A Agilent Technologies, Inc. 0.5×
ILMN Illumina, Inc. compare 0.5×
LH Labcorp Holdings Inc. compare 0.7×
DGX Quest Diagnostics Incorporated compare 0.7×
IQV IQVIA Holdings Inc. compare 2.5×
MTD Mettler-Toledo International, Inc. compare 165×
Diagnostics & Research industry median 0.1×
Healthcare sector median 0.0×
Market median 0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on A